subscribeSubscribe
NDMA issue persists as 2 more companies recall Nizatidine-based products

NDMA issue persists as 2 more companies recall Nizatidine-based products
KOREABIOMED
04 Jan 2022
Share Share
Enforcement Report - Week of May 6, 2020

Enforcement Report - Week of May 6, 2020
FDA
06 May 2020
Share Share
Health Canada Issues Recall of Pendopharm Division of Pharmascience`s AXID

Health Canada Issues Recall of Pendopharm Division of Pharmascience`s AXID
HEALTH CANADA
04 May 2020
Share Share
Amneal recalls ulcer drug on NDMA contamination fears

Amneal recalls ulcer drug on NDMA contamination fears
Kyle Blankenship FIERCE PHARMA
17 Apr 2020
Share Share
Amneal Pharmaceuticals,Issues Voluntary Nationwide Recall of Nizatidine Oral Solution

Amneal Pharmaceuticals,Issues Voluntary Nationwide Recall of Nizatidine Oral Solution
FDA
16 Apr 2020
Share Share
Enforcement Report - Week of January 29, 2020

Enforcement Report - Week of January 29, 2020
FDA
29 Jan 2020
Share Share
Mylan recalls close-to-expiration nizatidine capsules over NDMA impurity

Mylan recalls close-to-expiration nizatidine capsules over NDMA impurity
B. Hargreaves IN-PHARMATECHNOLOGIST
13 Jan 2020
Share Share
Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules

Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules
FDA
11 Jan 2020
Share Share
US-based Mylan Pharma initiates voluntary recall of Nizatidine Solara Active

US-based Mylan Pharma initiates voluntary recall of Nizatidine Solara Active
THEHINDUBUSINESSLINE
09 Jan 2020
Share Share
Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas

Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas
Y Eric Sagonowsky FIERCE PHARMA
09 Jan 2020
Share Share